Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Lenalidomide
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Lenalidomide
High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit
National Cancer Institute (NCI)P2CCC (53)
Leuporelin
Maligant Granulosa Cell Tumor Of Ovary
National Cancer Institute (NCI)P2CCC (53)
Loperamide
Cervical Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Loperamide
Ovarian Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Lurbinectedin
Urinary Bladder Small Cell Neuroendocrine Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Lurbinectedin
Bladder Small Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Luspatercept
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2CCC (53)
Luspatercept
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)P2CCC (53)
Methoxyamine
Lung Cancer
National Cancer Institute (NCI)P2CCC (53)
Mosunetuzumab
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Muamycin
Anal Canal Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Muamycin
Anal Margin Squamous Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Muamycin
HIV Infectious Disease
National Cancer Institute (NCI)P2CCC (53)
Muamycin
Squamous Cell Carcinoma Of Rectum
National Cancer Institute (NCI)P2CCC (53)
Muamycin
Rectal Cancer
National Cancer Institute (NCI)P2CCC (53)
muc1 peptide-poly-iclc vaccine
Colorectal Adenoma
National Cancer Institute (NCI)P2CCC (53)
muc1 peptide-poly-iclc vaccine
Colorectal Tubulovillous Adenoma
National Cancer Institute (NCI)P2CCC (53)
Muc-1 Peptide Vaccine
Colorectal Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Muc-1 Peptide Vaccine
Lynch Syndrome
National Cancer Institute (NCI)P2CCC (53)
Navitoclax
T-Lymphoblastic Lymphoma
National Cancer Institute (NCI)P2CCC (53)
Neratinib Maleate
Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Neratinib Maleate
Female Reproductive Organ Cancer
National Cancer Institute (NCI)P2CCC (53)
Neratinib Maleate
Cancer
National Cancer Institute (NCI)P2CCC (53)
Neratinib Maleate
Her2-Receptor Negative Breast Cancer
National Cancer Institute (NCI)P2CCC (53)
Showing 1651 to 1675 of 3,272 assets
PreviousPage 67 of 131Next